News releases Year None20212019 Dec 15, 2021 Pyxis to be Added to Russell 2000® Index PDF Version Dec 09, 2021 Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer PDF Version Nov 15, 2021 Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update PDF Version Nov 10, 2021 Pyxis Oncology to Present at the Jefferies London Healthcare Conference PDF Version Oct 07, 2021 Pyxis Announces Pricing of Upsized Initial Public Offering PDF Version Sep 14, 2021 Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer PDF Version Sep 08, 2021 Pyxis Oncology Strengthens Board of Directors PDF Version Aug 31, 2021 Pyxis Oncology Appoints Pamela Yanchik Connealy as Chief Financial Officer PDF Version Jun 08, 2021 Pyxis Oncology Strengthens Leadership Team with Executive and Scientific Advisory Board Appointments PDF Version May 25, 2021 Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14
Year None20212019 Dec 15, 2021 Pyxis to be Added to Russell 2000® Index PDF Version Dec 09, 2021 Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer PDF Version Nov 15, 2021 Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update PDF Version Nov 10, 2021 Pyxis Oncology to Present at the Jefferies London Healthcare Conference PDF Version Oct 07, 2021 Pyxis Announces Pricing of Upsized Initial Public Offering PDF Version Sep 14, 2021 Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer PDF Version Sep 08, 2021 Pyxis Oncology Strengthens Board of Directors PDF Version Aug 31, 2021 Pyxis Oncology Appoints Pamela Yanchik Connealy as Chief Financial Officer PDF Version Jun 08, 2021 Pyxis Oncology Strengthens Leadership Team with Executive and Scientific Advisory Board Appointments PDF Version May 25, 2021 Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14
